Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?
Corkum MT, Mitchell S, Venkatesan V, Read N, Warner A, Palma DA.
Adv Radiat Oncol. 2019 Jun 12;4(4):683-688. doi: 10.1016/j.adro.2019.06.001. eCollection 2019 Oct-Dec.
[Palliative demolitive surgery].
Caldarola L, Badellino F, Santoro L, Cardone B.
Minerva Med. 1975 May 9;66(35):1668-82.
Enhancing Label-Free Fluorescence Lifetime Imaging for Intraoperative Tumor Margin Delineation in Head and Neck Cancer using Data-Centric AI.
Hassan MA, Kraft L, Azam MA, Bec J, Hadfield KT, Qi J, Gui D, Bewley A, Abouyared M, Sorger J, Farwell G, Birkeland AC, Marcu L.
Res Sq [Preprint]. 2025 May 23:rs.3.rs-6673642. doi: 10.21203/rs.3.rs-6673642/v1.
A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
Teknos TN, Grecula J, Agrawal A, Old MO, Ozer E, Carrau R, Kang S, Rocco J, Blakaj D, Diavolitsis V, Kumar B, Kumar P, Pan Q, Palettas M, Wei L, Baiocchi R, Savvides P.
Invest New Drugs. 2019 Aug;37(4):702-710. doi: 10.1007/s10637-018-0696-4. Epub 2018 Dec 19.
PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Domínguez-Franjo P, Piris MA.
Am J Surg Pathol. 2008 Aug;32(8):1252-7. doi: 10.1097/PAS.0b013e318165b0d6.
Retromolar trigone--oropharynx junction maligns tumor surgery: transmandibular versus oral approach.
Cobzeanu BM, Popescu E, Costan VV, Ungureanu D, Cobzeanu MD.
Rev Med Chir Soc Med Nat Iasi. 2015 Jan-Mar;119(1):119-26.
